Tag Archives: CHSCO

Top 10 Performing Stocks To Own For 2019

Wynn Resorts (NASDAQ:WYNN) has been on a growth tear since opening Wynn Palace in Macau two years ago, but that’s not the end of the company’s ambitions. There’s room to expand in existing markets like Las Vegas and Macau, and new markets to conquer like Boston and Japan. 

The company’s second-quarter 2018 earnings conference call on Aug. 1 provided a lot of insight into how management is viewing growth opportunities and where it’s allocating capital for the future. 

Image source: Getty Images.

Macau still has room for growth

Wynn Palace is now Wynn Resorts’ best-performing property with $179.3 million of property EBITDA in the second quarter of 2018, but it isn’t as big as it can be, given 7 acres of undeveloped land adjacent to the existing site. CEO Matt Maddox stated that he has big plans for the land, with potential for another entertainment feature Wynn Resorts is known for: 

Top 10 Performing Stocks To Own For 2019: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

  • [By Ethan Ryder]

    Inogen Inc (NASDAQ:INGN) Director Heath Lukatch sold 500 shares of the firm’s stock in a transaction that occurred on Friday, October 5th. The shares were sold at an average price of $218.23, for a total value of $109,115.00. Following the sale, the director now owns 1,489 shares of the company’s stock, valued at approximately $324,944.47. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Jon C. Ogg]

    Inogen Inc. (NASDAQ: INGN) was downgraded to Buy from Strong Buy at Needham.

    Neurocrine Biosciences Inc. (NASDAQ: NBIX) was started as Overweight and assigned a $145 target price (versus a $116.93 close) at Morgan Stanley.

Top 10 Performing Stocks To Own For 2019: Friedman Industries Inc.(FRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Farad (CURRENCY:FRD) traded 24.6% higher against the dollar during the twenty-four hour period ending at 14:00 PM E.T. on June 28th. Farad has a market capitalization of $825,559.00 and approximately $54.00 worth of Farad was traded on exchanges in the last day. In the last seven days, Farad has traded up 3.4% against the dollar. One Farad token can currently be bought for about $0.0061 or 0.00000100 BTC on exchanges.

  • [By Stephan Byrd]

    Friedman Industries (NYSEAMERICAN:FRD) issued its quarterly earnings data on Tuesday. The company reported $0.51 earnings per share for the quarter, Bloomberg Earnings reports. The firm had revenue of $48.19 million for the quarter. Friedman Industries had a return on equity of 2.05% and a net margin of 1.19%.

Top 10 Performing Stocks To Own For 2019: Star Bulk Carriers Corp.(SBLK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Star Bulk Carriers (NASDAQ:SBLK) had its price target boosted by Morgan Stanley from $14.00 to $15.00 in a report issued on Wednesday morning. Morgan Stanley currently has an overweight rating on the shipping company’s stock.

  • [By Motley Fool Staff]

    Star Bulk Carriers (NASDAQ:SBLK) Q1 2018 Earnings Conference CallJun. 12, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Star Bulk Carriers (SBLK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Own For 2019: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 10 Performing Stocks To Own For 2019: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Max Byerly]

    Anika Therapeutics (NASDAQ: TNDM) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

  • [By Jon C. Ogg]

    Tandem Diabetes Care Inc. (NASDAQ: TNDM) was raised to Neutral from Underperform with a $45 price objective (versus a $38.61 close) at Merrill Lynch.

  • [By Keith Speights]

    Shares of Tandem Diabetes Care (NASDAQ:TNDM) were 10.9% higher as of 2:42 p.m. EDT on Thursday. Investors continued to drive up the insulin-pump maker’s stock following Tandem’s second-quarter update on Monday after the market closed. Tandem’s share price has risen more than 27% since the company announced its Q2 results.

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Todd Campbell]

    It’s not just drugmakers that are disrupting the massive diabetes market. Medical device makers are also developing new approaches that can help diabetics better control their disease. From medtech Goliaths Medtronic (NYSE:MDT) and Abbott Labs (NYSE:ABT) to small pure plays Dexcom (NASDAQ:DXCM), Insulet Corp. (NASDAQ:PODD), and Tandem Diabetes Care (NASDAQ:TNDM), we’ve got you covered.

Top 10 Performing Stocks To Own For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Avid Bioservices (NASDAQ:CDMO) and ESSA Pharma (NASDAQ:EPIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

Top 10 Performing Stocks To Own For 2019: Fortive Corporation (FTV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Fortive (FTV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Fortive Corporation  (NYSE:FTV)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Caption Management LLC bought a new stake in shares of Fortive Corp (NYSE:FTV) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 18,000 shares of the technology company’s stock, valued at approximately $1,388,000.

  • [By Max Byerly]

    Fortive Corp (NYSE:FTV) shares hit a new 52-week high during trading on Monday . The company traded as high as $87.72 and last traded at $87.43, with a volume of 180580 shares trading hands. The stock had previously closed at $87.03.

  • [By Stephan Byrd]

    Geneva Partners LLC lowered its position in Fortive Corp (NYSE:FTV) by 71.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,270 shares of the technology company’s stock after selling 25,357 shares during the quarter. Geneva Partners LLC’s holdings in Fortive were worth $792,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Fortive Corp (NYSE:FTV) has earned an average rating of “Buy” from the fourteen brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $81.00.

Top 10 Performing Stocks To Own For 2019: I.D. Systems, Inc.(IDSY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on I.D. Systems (IDSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get I.D. Systems alerts:

    I.D. Systems, Inc. (IDSY) Expected to Announce Quarterly Sales of $12.32 Million (americanbankingnews.com) I.D. Systems, Inc. (IDSY) Expected to Announce Earnings of $0.01 Per Share (americanbankingnews.com) I.D. Systems integrates Keytroller, forms PowerFleet division (mmh.com) I.D. Systems Integrates Keytroller and Forms PowerFleet® Division Focused on Industrial Truck Management Systems (finance.yahoo.com)

    Several analysts have commented on IDSY shares. National Securities started coverage on shares of I.D. Systems in a research note on Monday, August 27th. They issued a “buy” rating and a $8.60 price target on the stock. ValuEngine upgraded shares of I.D. Systems from a “sell” rating to a “hold” rating in a research note on Thursday, June 7th. Finally, Zacks Investment Research downgraded shares of I.D. Systems from a “hold” rating to a “sell” rating in a report on Wednesday, August 15th. Two analysts have rated the stock with a sell rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $9.32.

  • [By Shane Hupp]

    TRADEMARK VIOLATION NOTICE: “I.D. Systems, Inc. (IDSY) Major Shareholder Purchases $381,042.60 in Stock” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/4125843/i-d-systems-inc-idsy-major-shareholder-purchases-381042-60-in-stock.html.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on I.D. Systems (IDSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    xG Technology (NASDAQ: XGTI) and I.D. Systems (NASDAQ:IDSY) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends.

Top 10 Performing Stocks To Own For 2019: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Performing Stocks To Own For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Buy For 2019

Wall Street analysts expect that TechnipFMC (NYSE:FTI) will report earnings per share of $0.35 for the current fiscal quarter, according to Zacks Investment Research. Twenty Five analysts have provided estimates for TechnipFMC’s earnings. The highest EPS estimate is $0.46 and the lowest is $0.16. TechnipFMC posted earnings of $0.45 per share in the same quarter last year, which suggests a negative year over year growth rate of 22.2%. The business is expected to issue its next earnings results on Wednesday, July 25th.

According to Zacks, analysts expect that TechnipFMC will report full-year earnings of $1.33 per share for the current financial year, with EPS estimates ranging from $0.65 to $1.66. For the next financial year, analysts forecast that the business will post earnings of $1.49 per share, with EPS estimates ranging from $0.90 to $1.88. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side analysts that that provide coverage for TechnipFMC.

Top 5 Heal Care Stocks To Buy For 2019: City Holding Company(CHCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on City (CHCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Buy For 2019: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 5 Heal Care Stocks To Buy For 2019: Texas Instruments Incorporated(TXN)

Advisors’ Opinion:

  • [By Keith Speights]

    The way to determine where a puck is going to be requires evaluating its direction and speed. I used a similar approach to identify five stocks with fast-growing dividends: Boeing (NYSE:BA), Amgen (NASDAQ:AMGN), CVS Health (NYSE:CVS), Texas Instruments (NASDAQ:TXN), and AbbVie (NYSE:ABBV). Here’s why these stocks could be great picks for dividend-seeking investors.

  • [By Anders Bylund]

    Microchip veteran Texas Instruments (NASDAQ:TXN) just presented a bare-bones view of its second-quarter results. Tucked into the announcement of Chairman Rich Templeton taking back the CEO title again, the mini-report came in well above Wall Street’s expectations.

  • [By Shane Hupp]

    Texas Instruments (NASDAQ:TXN) updated its second quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $1.37 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.31. The company issued revenue guidance of $4.02 billion, compared to the consensus revenue estimate of $3.96 billion.

  • [By ]

    Texas Instruments (TXN)  trades for 18 times its 2019 GAAP EPS consensus of $5.67, and has an enterprise value equal to 16 times its expected 2019 FCF. The dividend yield is at 2.5%, and TI has committed to effectively returning all of its future FCF via dividends and buybacks.

  • [By ]

    Texas Instruments Inc. (TXN) and Teradyne Inc. (TER) are the next major semiconductor stocks to report, with financials expected after the closing bell on Tuesday, April 24.

  • [By Lisa Levin] Gainers
    Vicor Corporation (NASDAQ: VICR) rose 19.7 percent to $35 in pre-market trading. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 13.5 percent to $16.88 in pre-market trading after climbing 104.82 percent on Tuesday.
    Cree, Inc. (NASDAQ: CREE) shares rose 11.3 percent to $43.81 in pre-market trading as the company reported upbeat results for its third quarter on Tuesday.
    The Clorox Company (NYSE: CLX) rose 9.6 percent to $125.98 in pre-market trading.
    Aduro BioTech, Inc. (NASDAQ: ADRO) rose 5.8 percent to $7.25 in pre-market trading after falling 1.44 percent on Tuesday.
    STMicroelectronics N.V. (NYSE: STM) rose 5.2 percent to $22.42 in pre-market trading after reporting Q1 results.
    Twitter, Inc. (NYSE: TWTR) rose 5.2 percent to $32.05 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Credit Suisse Group AG (NYSE: CS) rose 5 percent to $17.11 in pre-market trading following strong Q1 results.
    Harmony Gold Mining Company Limited (NYSE: HMY) shares rose 4.4 percent to $2.02 in pre-market trading.
    22nd Century Group, Inc. (NYSE: XXII) rose 4.9 percent to $2.15 in pre-market trading after dropping 8.07 percent on Tuesday.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.1 percent to $102.40 in pre-market trading after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    iRobot Corporation (NASDAQ: IRBT) rose 3.3 percent to $61 in pre-market trading following upbeat quarterly earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 5 Heal Care Stocks To Buy For 2019: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Buy For 2019: W.R. Berkley Corporation(WRB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine cut shares of W. R. Berkley (NYSE:WRB) from a buy rating to a hold rating in a report released on Monday morning.

    WRB has been the topic of a number of other research reports. Bank of America cut shares of W. R. Berkley from a neutral rating to an underperform rating and set a $74.00 target price on the stock. in a report on Thursday, June 14th. They noted that the move was a valuation call. Zacks Investment Research cut shares of W. R. Berkley from a buy rating to a hold rating in a report on Tuesday, February 20th. Boenning Scattergood restated a hold rating on shares of W. R. Berkley in a report on Wednesday, April 25th. Finally, Goldman Sachs Group started coverage on shares of W. R. Berkley in a report on Monday. They set a sell rating and a $74.00 target price on the stock. They noted that the move was a valuation call. Four analysts have rated the stock with a sell rating and eight have issued a hold rating to the stock. W. R. Berkley currently has a consensus rating of Hold and a consensus price target of $70.78.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on W. R. Berkley (WRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on W. R. Berkley (WRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    W. R. Berkley (NYSE: WRB) and State Auto Financial (NASDAQ:STFC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Hot Performing Stocks To Own For 2019

March 20, 2017: Markets opened slightly lower Monday and traded close to the break-even line all day. Leading indicators and consumer sentiment readings were both strong. Only the materials sector traded high late in the afternoon while energy and utilities were the laggards. The blue chips were performing best. WTI crude oil for April delivery settled at $48.22 a barrel, down 1.2% on the day. April gold added 0.3% on the day to settle at $1,234.00. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.03% for the day, the S&P 500 traded down 0.14%, and the Nasdaq Composite traded up 0.02%.

Stocks traded very near the break-even line just minutes before the closing bell. The closing tally could finish with either a small gain or a small loss for any or all of the indexes.

The DJIA stock posting the largest daily percentage gain ahead of the close Monday was Caterpillar Inc. (NYSE: CAT) which traded up 2.66% at $95.38. The stock’s 52-week range is $69.04 to $99.46. Volume was roughly 15% below the daily average of around 5 million shares. The company reported a 1% decline in February retail sales this morning, the best year-over-year mark in more than 4 years.

Hot Performing Stocks To Own For 2019: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By Max Byerly]

    Electra (CURRENCY:ECA) traded 8% higher against the U.S. dollar during the 1-day period ending at 22:00 PM ET on June 20th. In the last week, Electra has traded 12.6% higher against the U.S. dollar. Electra has a market capitalization of $34.87 million and $128,874.00 worth of Electra was traded on exchanges in the last 24 hours. One Electra coin can now be purchased for $0.0014 or 0.00000020 BTC on exchanges including Fatbtc, Novaexchange, CoinFalcon and CryptoBridge.

  • [By Shane Hupp]

    Electra (CURRENCY:ECA) traded 3.4% lower against the dollar during the 24-hour period ending at 18:00 PM Eastern on June 4th. Electra has a total market capitalization of $45.83 million and approximately $326,372.00 worth of Electra was traded on exchanges in the last 24 hours. One Electra coin can currently be bought for $0.0018 or 0.00000024 BTC on cryptocurrency exchanges including Novaexchange, Octaex, Fatbtc and Cryptopia. In the last seven days, Electra has traded 12.8% higher against the dollar.

  • [By Keith Noonan, Travis Hoium, and Matthew DiLallo]

    We asked three Motley Fool investors to profile some of the best under-the-radar growth stocks on the market today. Read on to see why they selected Encana(NYSE:ECA), Activision Blizzard (NASDAQ:ATVI), and Baozun (NASDAQ:BZUN) as top growth stocks for in-the-know investors.

  • [By Max Byerly]

    Here are some of the news stories that may have effected Accern Sentiment’s rankings:

    Get Encana alerts:

    Encana Corp (ECA) Rising Higher 7.95% Over the Past Four Weeks (fisherbusinessnews.com) Encana Corporation (ECA) Most Active Stock Price trades 19.10% off from 200- SMA (nasdaqchronicle.com) Mid-Day Movers : Encana Corporation (NYSE:ECA), CSX Corporation (NASDAQ:CSX), MGIC Investment Corporation … (journalfinance.net) Featured Stock: Encana Corporation (ECA) (stockquote.review) Active Stock Evaluation Encana Corporation (NYSE: ECA) (financerater.com)

    ECA has been the subject of a number of research analyst reports. Morgan Stanley raised shares of Encana from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $15.00 to $18.00 in a report on Wednesday, January 24th. Evercore ISI raised shares of Encana from an “in-line” rating to an “outperform” rating and upped their price target for the company from $10.84 to $16.00 in a report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Encana from a “hold” rating to a “sell” rating in a report on Wednesday, January 31st. Scotiabank raised shares of Encana from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $13.00 to $14.00 in a report on Friday, February 16th. Finally, Goldman Sachs cut their price target on shares of Encana from $17.25 to $14.00 and set a “buy” rating for the company in a report on Friday, April 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $15.28.

  • [By Shane Hupp]

    Electra (CURRENCY:ECA) traded down 5.1% against the U.S. dollar during the 24-hour period ending at 15:00 PM E.T. on June 12th. Over the last seven days, Electra has traded down 25.7% against the U.S. dollar. Electra has a market cap of $34.53 million and approximately $134,011.00 worth of Electra was traded on exchanges in the last 24 hours. One Electra coin can currently be bought for $0.0013 or 0.00000020 BTC on exchanges including CryptoBridge, Fatbtc, CoinFalcon and Coinhouse.

Hot Performing Stocks To Own For 2019: Chunghwa Telecom Co., Ltd.(CHT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Evergreen Capital Management LLC purchased a new stake in shares of Chunghwa Telecom Co., Ltd (NYSE:CHT) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,755 shares of the utilities provider’s stock, valued at approximately $224,000.

  • [By Joseph Griffin]

    Chunghwa Telecom (NYSE: CHT) and NII (NASDAQ:NIHD) are both utilities companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

  • [By Joseph Griffin]

    News stories about Chunghwa Telecom (NYSE:CHT) have trended positive on Monday, according to Accern Sentiment. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chunghwa Telecom earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the utilities provider an impact score of 46.731481807669 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Hot Performing Stocks To Own For 2019: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.